AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75A50123C00048CODAGENIX INC
Overview
Award facts
- Net obligations
- $10.00M
- $10,000,000of $389.45M potential value
- Outlays (paid to date)
- $6.79M
- $6.79M paid of $10.00M obligated$6,794,012
- Period of performance
- Sep 30, 2023 to Jun 30, 2025
- Ended
- Modifications
- 8
- Latest action Mar 11, 2026
- Contract type
- Definitive contract
- PIID 75A50123C00048
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE.
Dates and value
- Award date
- Signed on Sep 27, 2023
- Potential end of performance
- Jul 30, 2026
- Current value
- $57,630,647Base and exercised options
- Potential value (if all options are exercised)
- $389,449,173
Obligations by fiscal year of action
- FY2023: $10,000,000
Total across 1 fiscal year: $10,000,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 11, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameCODAGENIX INC
LocationFARMINGDALE, NY
UEITEMNL437K2F1
CAGE code5D8K5
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCODAGENIX INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Farmingdale, Suffolk County, New York 11735-1019
- Congressional district (place of performance)
- NY-01As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN42HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 27, 2023Base obligation at award: $10,000,000
- Latest action
- Mar 11, 2026 — Other administrative actionModification P00008; administrative: no change in scope or value
- Latest substantive action
- Dec 6, 2024 — Supplemental agreement (within scope)Modification P00007
- Actions by type
- Base award1
- Supplemental agreement (within scope)4
- Other administrative action4
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 9
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-X-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $10,000,000
- COVID-19 supplemental outlays
- $6,794,012